|
Pineda J, Marín F, Marco P, Roldán V, Valencia J, Ruiz-Nodar JM, Sogorb F, Lip GY. Int J Cardiol. 2009 Aug 14;136(2):222-5. doi: 10.1016/j.ijcard.2008.04.020. Epub 2008 Jul 14. PubMed PMID: 18625524.
AÑO: 2009; IF: 3.469
|
18625524
|
López-Cuenca A, Marín F, Roldán V, Climent VE, Valdés M, Lip GY. Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. Int J Cardiol. 2010 Feb 18;139(1):95-7. doi: 10.1016/j.ijcard.2008.06.076. Epub 2008 Aug 22. PubMed PMID: 18722681.
AÑO: 2010; IF: 6.802
|
|
Sánchez-Quiñones J, Marín F, Roldán V, Lip GY. The impact of statin use on atrial fibrillation. QJM. 2008 Nov;101(11):845-61. doi: 10.1093/qjmed/hcn101. Epub 2008 Aug 24. Review. PubMed PMID: 18725372.
AÑO: 2008
|
|
Medina P, Navarro S, Corral J, Zorio E, Roldán V, Estellés A, Santamaría A, Marín F, Rueda J, Bertina RM, España F; RECAVA Thrombosis Groups. Endothelial protein C receptor polymorphisms and risk of myocardial infarction. Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066. PubMed PMID: 18757851.
AÑO: 2008; IF: 5.978
|
|
Roldán V, Marín F. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody. Thromb Haemost. 2008 Nov;100(5):754-5. PubMed PMID: 18989516.
AÑO: 2008; IF: 3.803
|